Director at STAAR Surgical (STAA) receives 7,524 long-dated options

Rhea-AI Filing Summary

STAAR Surgical director and 10% owner Neal C. Bradsher received an option grant to purchase 7,524 shares of common stock at an exercise price of $18.46 per share. The options expire on March 5, 2036 and are held directly.

The options will vest and become exercisable on the earlier of June 18, 2026 or the date of the company’s 2026 annual shareholder meeting, subject to his continuous service as a director. The grant was made on March 6, 2026 as director compensation under STAAR Surgical’s Amended and Restated Omnibus Equity Incentive Plan. Following this grant, Bradsher holds 7,524 options to purchase common stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Bradsher Neal C

Role Director, 10% Owner

Type	Security	Shares	Price	Value
Grant/Award	OPTION TO PURCHASE COMMON STOCK	7,524	$0.00	--

Holdings After Transaction: OPTION TO PURCHASE COMMON STOCK — 7,524 shares (Direct)

Footnotes (1)

1. These options will vest and become exercisable on the earlier of: (a) June 18, 2026 and (b) the date of STAAR Surgical Company's (the "Issuer") 2026 annual meeting of shareholders, subject, in each case, to Neal C. Bradsher's (the "Reporting Person") continuous service with the Issuer. These options were granted to the Reporting Person by the Issuer on March 6, 2026 as director compensation pursuant to the Issuer's Amended and Restated Omnibus Equity Incentive Plan, as amended.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bradsher Neal C

(Last) (First) (Middle)

C/O BROADWOOD CAPITAL, INC.

156 WEST 56TH STREET, 3RD FLOOR

(Street)

NEW YORK NY 10019

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
STAAR SURGICAL CO [ STAA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/06/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
OPTION TO PURCHASE COMMON STOCK	$18.46	03/06/2026		A		7,524		(1)	03/05/2036	COMMON STOCK	7,524	$0(2)	7,524	D

Explanation of Responses:

1. These options will vest and become exercisable on the earlier of: (a) June 18, 2026 and (b) the date of STAAR Surgical Company's (the "Issuer") 2026 annual meeting of shareholders, subject, in each case, to Neal C. Bradsher's (the "Reporting Person") continuous service with the Issuer.

2. These options were granted to the Reporting Person by the Issuer on March 6, 2026 as director compensation pursuant to the Issuer's Amended and Restated Omnibus Equity Incentive Plan, as amended.

	Neal C. Bradsher, /s/ Neal C. Bradsher	03/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did STAAR Surgical (STAA) report for Neal C. Bradsher?

STAAR Surgical reported that director and 10% owner Neal C. Bradsher received an option grant for 7,524 shares. The options were awarded as director compensation on March 6, 2026 under the company’s Amended and Restated Omnibus Equity Incentive Plan.

How many STAAR Surgical (STAA) options were granted to Neal C. Bradsher and at what price?

Neal C. Bradsher was granted options to purchase 7,524 shares of STAAR Surgical common stock at an exercise price of $18.46 per share. These options represent a compensation award for his service as a director of the company.

When do Neal C. Bradsher’s STAAR Surgical (STAA) options vest?

The options granted to Neal C. Bradsher will vest and become exercisable on the earlier of June 18, 2026 or the date of STAAR Surgical’s 2026 annual shareholder meeting. Vesting is conditioned on his continuous service with the company through that date.

What is the expiration date of Neal C. Bradsher’s STAAR Surgical (STAA) option grant?

The option grant to Neal C. Bradsher expires on March 5, 2036. After that date, any unexercised options will no longer be usable. This long-dated expiration is typical for equity compensation awarded to board members.

Why did STAAR Surgical (STAA) grant options to Neal C. Bradsher?

STAAR Surgical granted the options to Neal C. Bradsher as director compensation. The award was made pursuant to the company’s Amended and Restated Omnibus Equity Incentive Plan, aligning his incentives with long-term shareholder interests through equity-based pay.

How many STAAR Surgical (STAA) options does Neal C. Bradsher hold after this grant?

Following this transaction, Neal C. Bradsher holds 7,524 options to purchase STAAR Surgical common stock. This total reflects the options covered in the reported grant and is shown as his post-transaction derivative holdings in the filing.